Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • eREQUEST
  • COVID-19
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • eREQUEST
  • COVID-19

Expanded Access for Anti-IL8

Breadcrumb

  1. Home
  2. Expanded Access for Anti-IL8
Brief Summary

This is an expanded access designed to provide access to Anti-IL8 for eligible participants.

Status
Available
EA Type
Individual Patients
Interventions

Biological: Anti-IL8

Contacts

BMS Study Connect Contact Center www.BMSStudyConnect.com
855-907-3286
Clinical.Trials@bms.com

First line of the email MUST contain NCT # and Site #.

Investigators

Bristol-Myers Squibb
Study Director
Bristol-Myers Squibb

Sponsors / Collaborators
Bristol-Myers Squibb
NCT Number
NCT05210894

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
admin@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube
© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA